Chargement de la page
Logo of D.E.S is it, DES Action group in France (Diethylstilbestrol)

News with tag "neurodevelopmental disorders"

Portrait of depressed and sick man suffering from psychosis illness or mental disorder - DES (diethylstilbestrol ) exposure and psychiatric disorder, autism Asperger Scientific studies
Feb 2, 2020

Exposure to Diethylstilbestrol: mental illness and neurodevelopmental disorders in descendants

In France, diethylstilbestrol (DES) was prescribed to approximately 200,000 pregnant women between 1948 (sometimes before) and its ban in 1977 (sometimes after), under the brand names Distilbène®, Stilboestrol-Borne® and Furostilboestrol®, to prevent miscarriages and premature births.

We don't hear much about it ...

Read more
Prenatal exposure to synthetic sex hormones – including diethylstilbestrol – as a risk factor for autism spectrum disorders Scientific studies
Dec 24, 2022

Prenatal exposure to synthetic sex hormones – including diethylstilbestrol – as a risk factor for autism spectrum disorders

DES (a widespread abbreviation for diethylstilbestrol, a synthetic estrogen), has been marketed in the 1950s in many countries by different pharmaceutical companies (UCB Pharma, Borne, Eli Lilly...), under different brand names (Distilbene®, Stilboestrol-Borne®, Furostilboestrol®...) This drug, advertised as a new "miracle drug&...

Read more
Spinner - ADHD - attention-deficit hyperactivity disorder - diethylstilbestrol - consequences of DES - diethylstilbestrol Scientific studies
Jan 20, 2020

Exposure to Diethylstilbestrol (DES) linked to Attention Deficit Hyperactivity Disorder (ADHD) in Third Generation

Diethylstilbestrol (or DES – a commonly used abbreviation) is a well-known endocrine disruptor. In France, it has been marketed under the brand names Distilbène®, Stilboestrol-Borne® and Furostilboestrol®.

It was mainly prescribed to pregnant women between 1948 and 1977, where it was banned. Its main indication...

Read more